{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T17:10:18Z","timestamp":1756487418240,"version":"3.44.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,29]]},"DOI":"10.7759\/cureus.91244","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T16:33:56Z","timestamp":1756485236000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Artemether Versus Quinine for the Treatment of Cerebral Malaria in Children: A Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.7759","author":[{"given":"Hania","family":"Saeed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danyal","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Muneebullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Taimoor","family":"Faheem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha  H","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharjeel","family":"Azeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikram","family":"Syed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Allami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.939532","article-title":"Cerebral malaria induced by Plasmodium falciparum: clinical features, pathogenesis, diagnosis, and treatment","volume":"12","author":"Song X","year":"2022","unstructured":"Song X, Wei W, Cheng W, Zhu H, Wang W, Dong H, Li J. Cerebral malaria induced by Plasmodium falciparum: clinical features, pathogenesis, diagnosis, and treatment. Front Cell Infect Microbiol. 2022, 12:939532. 10.3389\/fcimb.2022.939532","journal-title":"Front Cell Infect Microbiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S125436","article-title":"Cerebral malaria: insight into pathogenesis, complications and molecular biomarkers","volume":"10","author":"Yusuf FH","year":"2017","unstructured":"Yusuf FH, Hafiz MY, Shoaib M, Ahmed SA. Cerebral malaria: insight into pathogenesis, complications and molecular biomarkers. Infect Drug Resist. 2017, 10:57-9. 10.2147\/IDR.S125436","journal-title":"Infect Drug Resist"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1203\/PDR.0b013e3181eee738","article-title":"Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome","volume":"68","author":"Idro R","year":"2010","unstructured":"Idro R, Marsh K, John CC, Newton CR. Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res. 2010, 68:267-74. 10.1203\/PDR.0b013e3181eee738","journal-title":"Pediatr Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199937020-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine","volume":"37","author":"White NJ","year":"1999","unstructured":"White NJ, van Vugt M, Ezzet F. Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine. Clin Pharmacokinet. 1999, 37:105-25. 10.2165\/00003088-199937020-00002","journal-title":"Clin Pharmacokinet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpara.2006.02.009","article-title":"Conventional and experimental treatment of cerebral malaria","volume":"36","author":"Golenser J","year":"2006","unstructured":"Golenser J, McQuillan J, Hee L, Mitchell AJ, Hunt NH. Conventional and experimental treatment of cerebral malaria. Int J Parasitol. 2006, 36:583-93. 10.1016\/j.ijpara.2006.02.009","journal-title":"Int J Parasitol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01493-8","article-title":"Establishment and evaluation of glucose-modified nanocomposite liposomes for the treatment of cerebral malaria","volume":"20","author":"Tian Y","year":"2022","unstructured":"Tian Y, Zheng Z, Wang X, et al.. Establishment and evaluation of glucose-modified nanocomposite liposomes for the treatment of cerebral malaria. J Nanobiotechnology. 2022, 20:318. 10.1186\/s12951-022-01493-8","journal-title":"J Nanobiotechnology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea BJ","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, et al.. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017, 358:j4008. 10.1136\/bmj.j4008","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins JP","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, et al.. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011, 343:d5928. 10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"ref10","unstructured":"The Cochrane Collaboration. Review-writing software. RevMan. (2014). https:\/\/www.cochrane.org\/learn\/courses-and-resources\/software."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins JP","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003, 327:557-60. 10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0035-9203(96)90260-6","article-title":"An open randomized trial of artemether versus quinine in the treatment of cerebral malaria in African children","volume":"90","author":"Murphy S","year":"1996","unstructured":"Murphy S, English M, Waruiru C, et al.. An open randomized trial of artemether versus quinine in the treatment of cerebral malaria in African children. Trans R Soc Trop Med Hyg. 1996, 90:298-301. 10.1016\/s0035-9203(96)90260-6","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0001-706x(99)00031-5","article-title":"Comparative efficacy of intramuscular artemether and intravenous quinine in Nigerian children with cerebral malaria","volume":"15","author":"Olumese PE","year":"1999","unstructured":"Olumese PE, Bj\u00f6rkman A, Gbadegesin RA, Adeyemo AA, Walker O. Comparative efficacy of intramuscular artemether and intravenous quinine in Nigerian children with cerebral malaria. Acta Trop. 1999, 15:231-6. 10.1016\/s0001-706x(99)00031-5","journal-title":"Acta Trop"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.1998.00166.x","article-title":"Intramuscular artemether vs intravenous quinine: an open, randomized trial in Malawian children with cerebral malaria","volume":"3","author":"Taylor TE","year":"1998","unstructured":"Taylor TE, Wills BA, Courval JM, Molyneux ME. Intramuscular artemether vs intravenous quinine: an open, randomized trial in Malawian children with cerebral malaria. Trop Med Int Health. 1998, 3:3-8. 10.1046\/j.1365-3156.1998.00166.x","journal-title":"Trop Med Int Health"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90423-e","article-title":"Rapid coma resolution with artemether in Malawian children with cerebral malaria","volume":"13","author":"Taylor TE","year":"1993","unstructured":"Taylor TE, Wills BA, Kazembe P, et al.. Rapid coma resolution with artemether in Malawian children with cerebral malaria. Lancet. 1993, 13:661-2. 10.1016\/0140-6736(93)90423-e","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(93)90092-5","article-title":"An open randomized comparative study of intramuscular artemether and intravenous quinine in cerebral malaria in children","volume":"87","author":"Walker O","year":"1993","unstructured":"Walker O, Salako LA, Omokhodion SI, Sowunmi A. An open randomized comparative study of intramuscular artemether and intravenous quinine in cerebral malaria in children. Trans R Soc Trop Med Hyg. 1993, 87:564-6. 10.1016\/0035-9203(93)90092-5","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607113350201","article-title":"A trial of artemether or quinine in children with cerebral malaria","volume":"335","author":"van Hensbroek MB","year":"1996","unstructured":"van Hensbroek MB, Onyiorah E, Jaffar S, et al.. A trial of artemether or quinine in children with cerebral malaria. N Engl J Med. 1996, 335:69-75. 10.1056\/NEJM199607113350201","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.330.7487.334","article-title":"Rectal artemether versus intravenous quinine for the treatment of cerebral malaria in children in Uganda: randomised clinical trial","volume":"330","author":"Aceng JR","year":"2005","unstructured":"Aceng JR, Byarugaba JS, Tumwine JK. Rectal artemether versus intravenous quinine for the treatment of cerebral malaria in children in Uganda: randomised clinical trial. BMJ. 2005, 330:334. 10.1136\/bmj.330.7487.334","journal-title":"BMJ"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.08.060327","article-title":"Artemisinin derivatives versus quinine for cerebral malaria in African children: a systematic review","volume":"87","author":"Kyu HH","year":"2009","unstructured":"Kyu HH, Fern\u00e1ndez E. Artemisinin derivatives versus quinine for cerebral malaria in African children: a systematic review. Bull World Health Organ. 2009, 87:896-904. 10.2471\/BLT.08.060327","journal-title":"Bull World Health Organ"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-7-210","article-title":"Artemisinin derivatives versus quinine in treating severe malaria in children: a systematic review","volume":"7","author":"Praygod G","year":"2008","unstructured":"Praygod G, de Frey A, Eisenhut M. Artemisinin derivatives versus quinine in treating severe malaria in children: a systematic review. Malar J. 2008, 7:210. 10.1186\/1475-2875-7-210","journal-title":"Malar J"},{"key":"ref21","unstructured":"Artemether injection. (2023). Accessed. n.d: https:\/\/www.severemalaria.org\/artemether-injection."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.21.2381","article-title":"Rectal administration of artemisinin derivatives for the treatment of malaria","volume":"297","author":"Karunajeewa HA","year":"2007","unstructured":"Karunajeewa HA, Manning L, Mueller I, Ilett KF, Davis TM. Rectal administration of artemisinin derivatives for the treatment of malaria. JAMA. 2007, 297:2381-90. 10.1001\/jama.297.21.2381","journal-title":"JAMA"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004009.pub3","article-title":"Intrarectal quinine versus intravenous or intramuscular quinine for treating Plasmodium falciparum malaria","volume":"2009","author":"Eisenhut M","year":"2009","unstructured":"Eisenhut M, Omari AA. Intrarectal quinine versus intravenous or intramuscular quinine for treating Plasmodium falciparum malaria. Cochrane Database Syst Rev. 2009, 2009:CD004009. 10.1002\/14651858.CD004009.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/B978-008055232-3.62502-4","article-title":"Quinine","author":"Scholar E","year":"2007","unstructured":"Scholar E. Quinine. xPharm. 2007, 1-6. 10.1016\/B978-008055232-3.62502-4","journal-title":"xPharm"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.293.6538.11","article-title":"Intramuscular loading dose of quinine for falciparum malaria: pharmacokinetics and toxicity","volume":"293","author":"Wattanagoon Y","year":"1986","unstructured":"Wattanagoon Y, Phillips RE, Warrell DA, Silamut K, Looareesuwan S, Nagachinta B, Back DJ. Intramuscular loading dose of quinine for falciparum malaria: pharmacokinetics and toxicity. Br Med J (Clin Res Ed). 1986, 293:11-3. 10.1136\/bmj.293.6538.11","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref26","unstructured":"Alternative and novel drug based prevention approaches. (2023). Accessed. June 15, 2023: https:\/\/www.cdc.gov\/malaria\/php\/public-health-strategy\/alternative-drug-prevention.html?CDC_AAref_Val=https:\/\/www.cdc...."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-97","article-title":"Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria","volume":"9","author":"Phu NH","year":"2010","unstructured":"Phu NH, Tuan PQ, Day N, et al.. Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria. Malar J. 2010, 9:97. 10.1186\/1475-2875-9-97","journal-title":"Malar J"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-018-2254-0","article-title":"The use and preference of artemether as a first-choice treatment for malaria: results from a cross-sectional survey in the Bata district, Equatorial Guinea","volume":"17","author":"Romay-Barja M","year":"2018","unstructured":"Romay-Barja M, Ncogo P, Nseng G, et al.. The use and preference of artemether as a first-choice treatment for malaria: results from a cross-sectional survey in the Bata district, Equatorial Guinea. Malar J. 2018, 17:107. 10.1186\/s12936-018-2254-0","journal-title":"Malar J"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-144","article-title":"Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria","volume":"10","author":"Achan J","year":"2011","unstructured":"Achan J, Talisuna AO, Erhart A, et al.. Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar J. 2011, 10:144. 10.1186\/1475-2875-10-144","journal-title":"Malar J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/398719-comparison-of-artemether-versus-quinine-for-the-treatment-of-cerebral-malaria-in-children-a-meta-analysis-of-randomized-controlled-trials","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T16:33:57Z","timestamp":1756485237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/398719-comparison-of-artemether-versus-quinine-for-the-treatment-of-cerebral-malaria-in-children-a-meta-analysis-of-randomized-controlled-trials"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.91244","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,29]]}}}